Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mouridsen

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Ugeskrift for Laeger|September 5, 1988
[Medical treatment of cancer--an elucidating report]P Dombernowsky, H H Hansen, N E Hansen, et al.
Ugeskrift for Laeger|January 1, 1997
[Medical treatment of cancer]Dombernowsky, H H Hansen, M Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group StudyJ Verweij, K Krzemieniecki, T Kok, et al.
Sarcoma|June 4, 2008
Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
Breast Cancer Research and Treatment|August 3, 2017
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98S Alkner, M-B Jensen, B B Rasmussen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patientsL Bastholt, C J Johansson, P Pfeiffer, et al.
The Oncologist|October 13, 2004
Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional abilityH Mouridsen, Y Sun, M Gershanovich, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group StudyG Blackledge, A van Oosterom, H Mouridsen, et al.
Endocrine-Related Cancer|June 11, 2005
Tissue inhibitor of metalloproteinases-1 in breast cancerS Ø Würtz, A-S Schrohl, N Møller Sørensen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group studyJ Verweij, I Judson, W Steward, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Ugeskrift for Laeger|September 5, 1988
[Medical treatment of cancer--an elucidating report]P Dombernowsky, H H Hansen, N E Hansen, et al.
Ugeskrift for Laeger|January 1, 1997
[Medical treatment of cancer]Dombernowsky, H H Hansen, M Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of miltefosine (hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult--an EORTC Soft Tissue and Bone Sarcoma Group StudyJ Verweij, K Krzemieniecki, T Kok, et al.
Sarcoma|June 4, 2008
Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
Breast Cancer Research and Treatment|August 3, 2017
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98S Alkner, M-B Jensen, B B Rasmussen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patientsL Bastholt, C J Johansson, P Pfeiffer, et al.
The Oncologist|October 13, 2004
Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional abilityH Mouridsen, Y Sun, M Gershanovich, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group StudyG Blackledge, A van Oosterom, H Mouridsen, et al.
Endocrine-Related Cancer|June 11, 2005
Tissue inhibitor of metalloproteinases-1 in breast cancerS Ø Würtz, A-S Schrohl, N Møller Sørensen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group studyJ Verweij, I Judson, W Steward, et al.
Pageof 6